(Q53291150)

English

Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy.

scientific article published on 13 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

chemoradiotherapy

0 references

cervical squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Juan Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Yan-lan Chai

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Tao Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Jin-hui Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Peng-gao Dai

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Zi Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

publication date

13 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

98

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

407-410

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Absence of epidermal growth factor receptor mutations in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Molecular profiling for personalized cancer care

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Exploiting the PI3K/AKT pathway for cancer drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

The Ras/Raf/MAPK pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Landscape of genomic alterations in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Carcinoma of the Cervix Uteri

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.03.014

7 January 2021

Identifiers

10.1016/J.YEXMP.2015.03.014

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/25773678

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53291150&oldid=1526226765"